Progression of pre-hypertension, stage 1 and 2 hypertension (JNC 7): A population-based study in Keelung, Taiwan (Keelung Community-based Integrated Screening No. 9)

Journal of Hypertension

Volumn 24, Issue 5, 2006, Pages 821-828

  Chiu, Yueh Hsia ^a,b   Wu, Shiao Chi ^a   Tseng, Chuen Den ^c   Yen, Ming Fang ^d   Chen, Tony Hsiu Hsi ^d  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b Health Bureau of Keelung City   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^d NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Hypertension; JNC 7 Report; Multi state transition; Pre hypertension

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN; LIPID;

ADULT; AGE; AGED; ANTHROPOMETRY; ARTICLE; BETEL NUT; BLOOD PRESSURE MEASUREMENT; BODY MASS; COHORT ANALYSIS; DISEASE COURSE; EXERCISE; FAMILY HISTORY; FEMALE; GENDER; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PARENT; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; REMISSION; RISK FACTOR; SCREENING; SMOKING; TAIWAN; WAIST CIRCUMFERENCE;

EID: 33646365372     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.hjh.0000222750.82820.19     Document Type: Article

References (20)

1. Insua JT, Sacks HS, Lau TS, Lau J, Reitman D, Pagano D, Chalmers TC. Drug treatment of hypertension in the elderly: a meta-analysis. Ann Int Med 1994; 121:355-362.
2. National Heart Foundation of Australia. Treatment of mild hypertension in the elderly. A study initiated and administered by the National Heart Foundation of Australia. Med J Aust 1981; 2:398-402.
3. SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA 1991; 265:3255-3264.
4. Maxwell MH, Ford CE. Cardiovascular morbidity and mortality in HDFP patients 50-69 years old at entry. J Cardiovasc Pharmacol 1985; 7 (suppl 2):S5-S9.
5. MRC Working Party. Medical Research Council trial of treatment of hypertension in older adults: principal results. BMJ 1992; 304:405-416.
6. Coope J, Warrender TS. Randomized trial of treatment of hypertension in the elderly patients in primary care. BMJ 1986; 293:1145-1148.
7. Amery A, Birkenhager W, Brixko P, Bulpitt C, Clement D, Deruyttere M, et al. Mortality and morbidity results from the European Working Party on High Blood Pressure in the Elderly trial. Lancet 1985; 1:1349-1354.
8. Veterans Administration Cooperative Study Group on Antihypertensive Agents. Effects of treatment on morbidity in hypertension. III. Influence of age, diastolic pressure, and prior cardiovascular disease; further analysis of side effects. Circulation 1972; 45:991-1004.
9. Dahlof B, Lindholm LH, Hansson L, Schersten B, Wester PO. Morbidity and mortality in the Swedish Trial in Old Patients with Hypertension (STOP-Hypertension). Lancet 1991; 338:1281-1285.
10. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, et al., and the National High Blood Pressure Education Program Coordinating Committee. The seventh report of the Joint National Committee on Prevention, Dectection, Evaluation, and Treatment of High Blood Pressure. The JNC 7 Report. JAMA 2003; 289:2560-2572.
11. Chen THH, Chiu YH, Luh DL, Yen MF, Wu HM, Chen LS, et al. Community-based multiple screening model: design, implementation, and analysis of 42,387 participants. Cancer 2004; 100:1734-1743.
12. Greenlund KJ, Croft JB, Mensah GA. Prevalence of heart disease and stroke risk factors in persons with pre-hypertension in the United States, 1999-2000. Arch Intern Med 2004; 164:2113-2118.
13. Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension: analysis of worldwide data. Lancet 2005; 365:217-223.
14. Hajjar I, Kotchen TA. Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000. JAMA 2003; 290:199-206.
15. Pan WH, Chang HY, Yeh WT, Hsiao SY, Hung YT. Prevalence, awareness, treatment and control of hypertension in Taiwan: results of nutrition and health survey in Taiwan (NAHSIT) 1993-1996. J Hum Hypertens 2001; 15:793-798.
16. Writing group of the PREMIER collaborative research group. Effects of comprehensive lifestyle modification on blood pressure control: Main results of the PREMIER clinical trial. JAMA 2003; 289:2083-2093.
17. Vasan RS, Beiser A, Seshadri S, Larson MG, Kannel WB, D'Agostino RB, Levy D. Residual lifetime risk for developing hypertension in middle-aged women and men: The Framingham Heart Study. JAMA 2002; 287:1003-1010.
18. Chen CH, Lin HC, Kuo HS, Chang MS, Chou P. Epidemiology of hypertension in Kin-Hu, Kinmen. Am J Hypertens 1995; 8:395-403.
19. Chen CH, Tsai ST, Chuang JH, Chang MS, Wang SP, Chou P. Population-based study of insulin, C-peptide, and blood pressure in Chinese with normal glucose tolerance. Am J Cardiol 1995; 76:585-588.
20. Vasan RS, Larson MG, Leip EP, Kannel WB, Levy D. Assessment of frequency of progression to hypertension in non-hypertensive participants in the Framingham Heart Study: a cohort study. Lancet 2001; 358:1286-1682.